Author

Alberto Bigogno

European Institute of Oncology

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Assay:CITE-seq· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Approach:genetic perturbation / CRISPR· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1

Frequent Co-Authors

Carina B. Nava LausoniD· 1 shared Carlotta CatozziiD· 1 shared Christoph Heuser-LoyiD· 1 shared Ciro MercurioiD· 1 shared Dorothee HaasiD· 1 shared Elena CeccacciiD· 1 shared Eleonora SalaiD· 1 shared Elisa Preto· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Carina B. Nava LausonORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

ImmunologyNature CommunicationsPeer-reviewedAug 27, 2024

LSD1 inhibition improves efficacy of adoptive T cell therapy by enhancing CD8+ T cell responsiveness.

Isabella Pallavicini, Teresa Maria Frasconi, Carlotta Catozzi…·Teresa Manzo

This study shows that inhibiting LSD1 enhances CD8+ T cell function in adoptive T cell therapy, leading to improved antitumor immunity and synergistic effects with anti-PDL1 therapy.

22 citations

mouseCITE-seq

𝕏 PostBluesky